General Information of Drug Off-Target (DOT) (ID: OTY6MIZ9)

DOT Name Testis-expressed protein 19 (TEX19)
Gene Name TEX19
Related Disease
Advanced cancer ( )
Bladder cancer ( )
Epithelial ovarian cancer ( )
Neoplasm ( )
Ovarian cancer ( )
Ovarian neoplasm ( )
Urinary bladder cancer ( )
Urinary bladder neoplasm ( )
UniProt ID
TEX19_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF15553
Sequence
MCPPVSMRYEEEGMSYLYASWMYQLQHGDQLSICFTCFKAAFLDFKDLLESEDWEEDNWD
PELMEHTEAESEQEGSSGMELSWGQSPGQPVQGGSEAWGPGTLAAAPEGLEDAGLDPHFV
PTELWPQEAVPLGLGLEDADWTQGLPWRFEELLTCSHWPSFFPS
Function
Required during spermatogenesis and placenta development, participating in the repression of retrotransposable elements and prevent their mobilization. Collaborates with the Piwi-interacting RNA (piRNA) pathway, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins. Interacts with Piwi proteins and directly binds piRNAs, a class of 24 to 30 nucleotide RNAs that are generated by a Dicer-independent mechanism and are primarily derived from transposons and other repeated sequence elements. Also during spermatogenesis, promotes, with UBR2, SPO11-dependent recombination foci to accumulate and drive robust homologous chromosome synapsis. Interacts with LINE-1 retrotransposon encoded LIRE1, stimulates LIRE1 polyubiquitination, mediated by UBR2, and degradation, inhibiting LINE-1 retrotransposon mobilization.
Tissue Specificity Expressed in testis. Expressed in undifferentiated embryonic stem cells.

Molecular Interaction Atlas (MIA) of This DOT

8 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Advanced cancer DISAT1Z9 Strong Biomarker [1]
Bladder cancer DISUHNM0 Strong Altered Expression [2]
Epithelial ovarian cancer DIS56MH2 Strong Altered Expression [3]
Neoplasm DISZKGEW Strong Altered Expression [1]
Ovarian cancer DISZJHAP Strong Altered Expression [3]
Ovarian neoplasm DISEAFTY Strong Altered Expression [3]
Urinary bladder cancer DISDV4T7 Strong Altered Expression [2]
Urinary bladder neoplasm DIS7HACE Strong Altered Expression [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Testis-expressed protein 19 (TEX19). [4]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Testis-expressed protein 19 (TEX19). [8]
------------------------------------------------------------------------------------
10 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Quercetin DM3NC4M Approved Quercetin increases the expression of Testis-expressed protein 19 (TEX19). [5]
Temozolomide DMKECZD Approved Temozolomide increases the expression of Testis-expressed protein 19 (TEX19). [6]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Testis-expressed protein 19 (TEX19). [7]
Leflunomide DMR8ONJ Phase 1 Trial Leflunomide increases the expression of Testis-expressed protein 19 (TEX19). [9]
THAPSIGARGIN DMDMQIE Preclinical THAPSIGARGIN increases the expression of Testis-expressed protein 19 (TEX19). [10]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the expression of Testis-expressed protein 19 (TEX19). [11]
Trichostatin A DM9C8NX Investigative Trichostatin A increases the expression of Testis-expressed protein 19 (TEX19). [12]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of Testis-expressed protein 19 (TEX19). [13]
Acetaldehyde DMJFKG4 Investigative Acetaldehyde increases the expression of Testis-expressed protein 19 (TEX19). [14]
crotylaldehyde DMTWRQI Investigative crotylaldehyde increases the expression of Testis-expressed protein 19 (TEX19). [15]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)

References

1 Human germ/stem cell-specific gene TEX19 influences cancer cell proliferation and cancer prognosis.Mol Cancer. 2017 Apr 26;16(1):84. doi: 10.1186/s12943-017-0653-4.
2 Testis expressed 19 is a novel cancer-testis antigen expressed in bladder cancer.Tumour Biol. 2016 Jun;37(6):7757-65. doi: 10.1007/s13277-015-4567-8. Epub 2015 Dec 22.
3 TEX19 promotes ovarian carcinoma progression and is a potential target for epitope vaccine immunotherapy.Life Sci. 2020 Jan 15;241:117171. doi: 10.1016/j.lfs.2019.117171. Epub 2019 Dec 13.
4 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
5 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
6 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
7 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
8 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
9 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
10 Chemical stresses fail to mimic the unfolded protein response resulting from luminal load with unfolded polypeptides. J Biol Chem. 2018 Apr 13;293(15):5600-5612.
11 Global gene expression analysis reveals novel transcription factors associated with long-term low-level exposure of EA.hy926 human endothelial cells to bisphenol A. Chem Biol Interact. 2023 Aug 25;381:110571. doi: 10.1016/j.cbi.2023.110571. Epub 2023 May 25.
12 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
13 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
14 Transcriptome profile analysis of saturated aliphatic aldehydes reveals carbon number-specific molecules involved in pulmonary toxicity. Chem Res Toxicol. 2014 Aug 18;27(8):1362-70.
15 Gene expression profile and cytotoxicity of human bronchial epithelial cells exposed to crotonaldehyde. Toxicol Lett. 2010 Aug 16;197(2):113-22.